|
Sojo-Dorado J, Lopez-Hernandez I, Hernandez-Torres A, Retamar-Gentil P, Merino de Lucas E, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jimenez V, Docobo-Perez F, Pascual A, Rodriguez-Bano J. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. J Antimicrob Chemother. 2023 Jul 5;78(7):1658-1666. doi: 10.1093/jac/dkad147. PubMed PMID: 37260299; PubMed Central PMCID: PMC10775153.
AÑO: 2023; IF: 3.9
|
37260299
|
Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo A, Diaz-Pena R; Scourge Cohort Group. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19. HLA. 2023 Dec;102(6):731-739. doi: 10.1111/tan.15160. Epub 2023 Aug 1. PubMed PMID: 37528566.
AÑO: 2023; IF: 5.9
|
|
Pericas JM, Llopis J, Munoz P, Gonzalez-Ramallo V, Garcia-Leoni ME, de Alarcon A, Luque R, Farinas MC, Goenaga MA, Hernandez-Meneses M, Nicolas D, Ramos-Martinez A, Rodriguez-Esteban MA, Villoslada-Gelabert A, Miro JM; GAMES Investigators. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria. Open Forum Infect Dis. 2022 Aug 30;9(9):ofac442. doi: 10.1093/ofid/ofac442. eCollection 2022 Sep. PubMed PMID: 36172059; PubMed Central PMCID: PMC9512706.
AÑO: 2022; IF: 4.2
|
|
Escrihuela-Vidal F, Berbel D, Fernandez-Hidalgo N, Escola-Verge L, Munoz P, Olmedo M, Goenaga MA, Goikoetxea J, Farinas MC, De Alarcon A, Miro JM, Ojeda G, Plata A, Cuervo G, Carratala J; GAMES Investigators. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci. Clin Infect Dis. 2023 Nov 11;77(9):1273-1281. doi: 10.1093/cid/ciad375. PubMed PMID: 37345869.
AÑO: 2023; IF: 8.2
|
|
Vazquez C, Garcia-Vazquez E, Carrilero B, Muro M, Sanchez-Guerrero I, Gonzalez Lopez R, Franco F, Segovia M. Anticipating the side effects of benznidazole: HLA-B*35 and patch test. Enferm Infecc Microbiol Clin (Engl Ed). 2024 Oct;42(8):430-434. doi: 10.1016/j.eimce.2024.04.011. Epub 2024 Jun 19. PubMed PMID: 38902151.
AÑO: 2024
|